---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-23-001762"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2023-09-29T23:59:59+00:00"
generated_at: "2026-06-10T06:54:20.669642+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Renovaro to acquire AI health company GEDi Cube in stock-for-stock deal; combined company to focus on precision medicine

## Summary
- GEDi Cube holders to receive ~50% of Renovaro common stock (subject to adjustments); supermajority (78%) of GEDi holders support deal.
- Transaction expected to close late Q4 2023 or early 2024, subject to Renovaro shareholder approval and other conditions.
- Combined company plans to launch AI-based commercial diagnostic products in 2024; Renovaro aims to start Phase 1/2 pancreatic cancer trial in H2 2024.
- GEDi Cube validated early lung cancer diagnosis at a university hospital; technology targets 12 additional cancers including pancreatic and breast.
- Renovaro's pre-clinical and clinical data expected to accelerate GEDi's AI, which in turn could advance Renovaro's therapy development.

## SEC filing metadata
- accession: 0001731122-23-001762
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2023-09-29T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112223001762/0001731122-23-001762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112223001762/e5071_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-23-001762
- JSON: https://secwatch.observer/filing/0001731122-23-001762.json
- Plain text: https://secwatch.observer/filing/0001731122-23-001762.txt

## Key facts
- Material Agreements
  Lunai Bioworks Inc. entered into Purchase Agreement with GEDi Cube Intl Ltd. (effective 2023-09-28).
  - Action: entry
  - Agreement: merger
  - Counterparty: GEDi Cube Intl Ltd.
  - Effective: 2023-09-28
  source text: On September 28, 2023, Renovaro Biosciences Inc. (NASDAQ: RENB) (“ Renovaro ”), entered into a Stock Purchase Agreement (the “ Purchase Agreement ”) with GEDi Cube Intl Ltd.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112223001762/0001731122-23-001762-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.